Sign in
TerminatedNo phase

The Leaflex™ Standalone Study Protocol

Key facts

Who runs it
Pi-cardia
Where
Hungary1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
33 people enrolled
Started
2 Sept 2020
Ended
14 Aug 2024
Type of study
Interventional
Treatments tested
  • Leaflex™ Performer
Record updated
28 February 2025
Why it stopped
The study was terminated after completion of the Exploratory phase due to reprioritization of attention and resources by Sponsor.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Patient with symptomatic, severe aortic stenosis who are not recommended by the heart team for immediate treatment with surgical or transcatheter aortic valve replacement
  • Patient is willing to comply with scheduled visits and tests and is able and willing to provide informed consent

Who cannot take part

  • Coronary, carotid, or vertebral artery disease that, in the opinion of the heart team, should be treated; or treatment of coronary artery disease ≤ 1 month prior to index procedure
  • Aortic balloon valvuloplasty ≤ 3 months prior to index procedure
  • Stroke ≤ 12 months prior to index procedure
  • History of a myocardial infarction ≤ 6 weeks prior to index procedure
  • Ongoing severe infection, including endocarditis, or sepsis
  • Patients with clinically significant abnormality in cell blood count, history of bleeding diathesis or coagulopathy
  • Left ventricle ejection fraction <30%
  • Moderate or greater aortic regurgitation
  • Anatomic contraindications
  • Hemodynamic instability
  • Hypertrophic cardiomyopathy with obstruction
  • Life expectancy ≤ 12 months

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A prospective, multicenter, single-arm study aimed to assess safety and performance of the Leaflex™ Performer in the treatment of patients with symptomatic, severe aortic stenosis.

Read full original descriptionShow less

Subjects will be seen at pre- and post procedure, discharge, 30 days and at 3, 6, 9 and 12 months post procedure.

The group in the trial

  • Leaflex™ PerformerTreatment being tested

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
28 February 2025